Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Samira Sakhia Insider Profile
4 Followers
Samira Sakhia, Director at Antibe Therapeutics, holds 278.28K shares in Knight Therapeutics (Ticker: KHTRF), holds 13.78K shares in Nuvo Pharmaceuticals (Ticker: TSE:MRV), holds 250.00K shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, Samira Sakhia Bought ― shares of Knight Therapeutics on Nov 12, 2024 for an estimated value of 103.00K.
Profitable Transactions
4 out of 15 Profitable Transactions
Average Return
-4.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Samira Sakhia holds in companies
Most Profitable Insider Trade
Stock:
Nuvo Pharmaceuticals
(MRV)
(MRV)
Rating:Informative Buy
Date:Jan 07, 2016 - Jan 07, 2017
Return:+53.00%
The most profitable trade made by Samira Sakhia
Samira Sakhia's Trading History
Antibe Therapeutics
Apr 07, 2015
Director
Informative Buy
25.00K
$53.75K
Knight Therapeutics
Nov 12, 2024
President & Chief Executive Officer
Informative Buy
103.00K
$1.02M
Nuvo Pharmaceuticals
Mar 07, 2016
―
Uninformative Buy
―
C$18.53K
List of latest transactions for each holding click on a transaction to see Samira Sakhia's performance on stock
You May Also Like
Samira Sakhia insider profile FAQ
What is the percentage of profitable transactions made by Samira Sakhia?
The percentage of profitable transactions made by Samira Sakhia is 27%.
What is the average return per transaction made by Samira Sakhia?
The average return per transaction made by Samira Sakhia is -4.80%.
What stocks does Samira Sakhia hold?
Samira Sakhia holds: ATBPF, KHTRF, TSE:MRV stocks.
What was Samira Sakhia’s latest transaction?
Samira Sakhia latest transaction was an Informative Buy of $103.00K.
What was Samira Sakhia's most profitable transaction?
Samira Sakhia’s most profitable transaction was an Informative Buy of TSE:MRV stock on January 7, 2016. The return on the trade was 53.00%.
What is Samira Sakhia's role in Antibe Therapeutics?
Samira Sakhia's role in Antibe Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.